Company Overview

AI/ML Innovations Inc. is a technology company focused on the development and commercialization of artificial intelligence and machine learning–driven solutions, with an emphasis on healthcare and data analytics applications. The company operates at the intersection of artificial intelligence, machine learning, and digital health, aiming to apply predictive analytics and automation to improve clinical decision-making and operational efficiency. Its common shares trade on the over-the-counter market under the ticker AIMLF, and the company is also publicly listed in Canada.

The company’s business model centers on developing proprietary AI/ML platforms and pursuing commercialization through partnerships and targeted deployments rather than large-scale consumer distribution. Public disclosures indicate that AI/ML Innovations Inc. has evolved from an early-stage technology developer into a company seeking revenue-generating use cases in regulated industries, particularly healthcare. However, details on long-term operating history and early-stage evolution remain limited in publicly available filings, and some historical information is data inconclusive based on available public sources.

Business Operations

AI/ML Innovations Inc. reports its operations as primarily focused on a single operating segment centered on AI/ML software development and applied analytics. Revenue generation, where disclosed, is derived from software licensing, proof-of-concept deployments, and collaboration agreements, primarily within healthcare-related environments. The company emphasizes data-driven insights, predictive modeling, and clinical or operational optimization tools rather than hardware or infrastructure ownership.

The company operates with a relatively asset-light structure, relying on internally developed intellectual property and third-party cloud infrastructure. Public disclosures reference strategic collaborations and pilot programs, but detailed breakdowns of revenue by customer, geography, or contract type are not consistently disclosed. Information regarding specific subsidiaries, joint ventures, or material long-term commercial contracts is data inconclusive based on available public sources.

Strategic Position & Investments

Strategically, AI/ML Innovations Inc. positions itself as an applied AI company targeting niche, high-value use cases rather than mass-market AI platforms. Growth initiatives described in public materials include advancing proprietary algorithms, validating solutions in real-world healthcare settings, and expanding commercialization through institutional and enterprise partnerships. The company has indicated a focus on regulated markets where barriers to entry may provide defensible positioning once products are validated.

Public information does not consistently identify major acquisitions, controlling investments, or a diversified portfolio of operating subsidiaries. While management communications reference potential expansion into adjacent AI-enabled sectors, specific capital commitments, completed acquisitions, or material equity investments cannot be independently verified. As a result, details regarding investments and emerging technology exposure are data inconclusive based on available public sources.

Geographic Footprint

AI/ML Innovations Inc. is headquartered in Canada, with its primary corporate, development, and administrative functions based there. The company’s public disclosures suggest a primary operational focus on the North American market, particularly Canada and the United States, where healthcare AI adoption and regulatory frameworks are more clearly defined.

Beyond North America, there is limited verified information indicating material operations, offices, or revenue contributions from other regions. Any international market presence appears to be exploratory or partnership-based rather than supported by owned infrastructure or dedicated regional teams. Consequently, the extent of global operational influence outside North America is data inconclusive based on available public sources.

Leadership & Governance

AI/ML Innovations Inc. is led by an executive team with experience in technology development, data analytics, and corporate management. Leadership communications emphasize disciplined commercialization, validation-driven growth, and the responsible deployment of AI technologies in sensitive domains such as healthcare. The company is governed by a board of directors consistent with public company requirements, though detailed committee structures and governance practices are not fully disclosed in all public materials.

Key executives publicly associated with the company include:

• Tim Daniels – Chief Executive Officer
• Paul Duffy – Chief Financial Officer
• Geoff Harries – Director

While these individuals are consistently referenced in company disclosures and market reporting, comprehensive biographies and governance frameworks are not uniformly available across all regulatory documents. Any additional executive roles or leadership responsibilities beyond those listed above are data inconclusive based on available public sources.